- Home
- TMQ vs BYSI Comparison
TMQ vs BYSI Comparison
Compare TMQ & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- BYSI
- Stock Information
- Founded
- TMQ 2004
- BYSI 2010
- Country
- TMQ Canada
- BYSI United States
- Employees
- TMQ N/A
- BYSI N/A
- Industry
- TMQ Precious Metals
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- TMQ Basic Materials
- BYSI Health Care
- Exchange
- TMQ Nasdaq
- BYSI Nasdaq
- Market Cap
- TMQ 83.6M
- BYSI 69.3M
- IPO Year
- TMQ N/A
- BYSI 2017
- Fundamental
- Price
- TMQ $1.20
- BYSI $1.72
- Analyst Decision
- TMQ
- BYSI
- Analyst Count
- TMQ 0
- BYSI 0
- Target Price
- TMQ N/A
- BYSI N/A
- AVG Volume (30 Days)
- TMQ 224.1K
- BYSI 21.8K
- Earning Date
- TMQ 02-07-2025
- BYSI 01-01-0001
- Dividend Yield
- TMQ N/A
- BYSI N/A
- EPS Growth
- TMQ N/A
- BYSI N/A
- EPS
- TMQ N/A
- BYSI N/A
- Revenue
- TMQ N/A
- BYSI $1,876,000.00
- Revenue This Year
- TMQ N/A
- BYSI N/A
- Revenue Next Year
- TMQ N/A
- BYSI N/A
- P/E Ratio
- TMQ N/A
- BYSI N/A
- Revenue Growth
- TMQ N/A
- BYSI 21.03
- 52 Week Low
- TMQ $0.25
- BYSI $0.82
- 52 Week High
- TMQ $1.40
- BYSI $4.00
- Technical
- Relative Strength Index (RSI)
- TMQ 57.45
- BYSI 52.47
- Support Level
- TMQ $1.10
- BYSI $1.58
- Resistance Level
- TMQ $1.24
- BYSI $1.75
- Average True Range (ATR)
- TMQ 0.06
- BYSI 0.09
- MACD
- TMQ -0.00
- BYSI 0.02
- Stochastic Oscillator
- TMQ 77.78
- BYSI 74.07
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.